CML (CHRONIC MYELOGENOUS LEUKEMIA)

Clinical trials for CML (CHRONIC MYELOGENOUS LEUKEMIA) explained in plain language.

Never miss a new study

Get alerted when new CML (CHRONIC MYELOGENOUS LEUKEMIA) trials appear

Sign up with your email to follow new studies for CML (CHRONIC MYELOGENOUS LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for blood cancer patients: trial tests better protection after transplants

Disease control Recruiting now

This study aims to find the best drug combination to prevent graft-versus-host disease (GVHD), a serious complication where donor immune cells attack the patient's body after a stem cell transplant. Researchers are comparing two new drug combinations against the current standard …

Matched conditions: CML (CHRONIC MYELOGENOUS LEUKEMIA)

Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

CML (CHRONIC MYELOGENOUS LEUKEMIA)

Get alerted when new CML (CHRONIC MYELOGENOUS LEUKEMIA) trials appear

New hope for blood cancer patients: trial tests better protection after transplants